Vitespen Not Yet Recruiting Phase 2 Trials for Glioma of Brain Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03650257A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96